Zobrazeno 1 - 10
of 266
pro vyhledávání: '"Andreas Meyerhans"'
Autor:
Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, Mireya L. Borrajo, Gustavo Lou, Lorenzo Franceschini, Ignasi Esteban, Pedro J. Sánchez-Cordón, Carmen Zamora, Carlos Óscar S. Sorzano, Luis Jordá, Laia Codó, Josep L. Gelpí, Marta Sisteré-Oró, Andreas Meyerhans, Kris Thielemans, Francisco Martínez-Jiménez, Núria López-Bigas, Felipe García, María J. Alonso, Montserrat Plana, Mariano Esteban, Carmen Elena Gómez
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-15 (2024)
Abstract Vaccines based on mRNA technology have revolutionized the field. In fact, lipid nanoparticles (LNP) formulated with mRNA are the preferential vaccine platform used in the fight against SARS-CoV-2 infection, with wider application against oth
Externí odkaz:
https://doaj.org/article/9161a691dc534dadb8067291bb76b860
Autor:
Laura Marcos-Villar, Beatriz Perdiguero, María López-Bravo, Carmen Zamora, Laura Sin, Enrique Álvarez, Carlos Óscar S. Sorzano, Pedro J. Sánchez-Cordón, José M. Casasnovas, David Astorgano, Juan García-Arriaza, Shubaash Anthiya, Mireya L. Borrajo, Gustavo Lou, Belén Cuesta, Lorenzo Franceschini, Josep L. Gelpí, Kris Thielemans, Marta Sisteré-Oró, Andreas Meyerhans, Felipe García, Ignasi Esteban, Núria López-Bigas, Montserrat Plana, María J. Alonso, Mariano Esteban, Carmen Elena Gómez
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
Despite the high efficiency of current SARS-CoV-2 mRNA vaccines in reducing COVID-19 morbidity and mortality, waning immunity and the emergence of resistant variants underscore the need for novel vaccination strategies. This study explores a heterolo
Externí odkaz:
https://doaj.org/article/249ddc44798e493a9e82b35d7493dba3
Autor:
Valentina Casella, Eva Domenjo-Vila, Anna Esteve-Codina, Mireia Pedragosa, Paula Cebollada Rica, Enric Vidal, Ivan de la Rubia, Cristina López-Rodríguez, Gennady Bocharov, Jordi Argilaguet, Andreas Meyerhans
Publikováno v:
Cell Death and Disease, Vol 14, Iss 12, Pp 1-13 (2023)
Abstract Acute infection and chronic infection are the two most common fates of pathogenic virus infections. While several factors that contribute to these fates are described, the critical control points and the mechanisms that underlie infection fa
Externí odkaz:
https://doaj.org/article/dd0fc59a75174ebaada2f5ec64e26ee9
Autor:
Macauley Locke, Dmitry Grebennikov, Igor Sazonov, Martín López-García, Marina Loguinova, Andreas Meyerhans, Gennady Bocharov, Carmen Molina-París
Publikováno v:
Mathematics, Vol 12, Iss 12, p 1904 (2024)
SARS-CoV-2 still presents a global threat to human health due to the continued emergence of new strains and waning immunity among vaccinated populations. Therefore, it is still relevant to investigate potential therapeutics, such as therapeutic inter
Externí odkaz:
https://doaj.org/article/e580730213d44c279e42581e2f64c47c
Autor:
Valentina Casella, Paula Cebollada Rica, Jordi Argilaguet, Enric Vidal, María González-Cao, Roberto Güerri-Fernandez, Gennady Bocharov, Andreas Meyerhans
Publikováno v:
Viruses, Vol 16, Iss 5, p 799 (2024)
Immunotherapy with checkpoint inhibitors, albeit commonly used against tumors, is still at its infancy against chronic virus infections. It relies on the reinvigoration of exhausted T lymphocytes to eliminate virus-infected cells. Since T cell exhaus
Externí odkaz:
https://doaj.org/article/05b3bfd9423f4bad98694a638d985b6e
Autor:
Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, Mireya L. Borrajo, Gustavo Lou, Lorenzo Franceschini, Ignasi Esteban, Pedro J. Sánchez-Cordón, Carmen Zamora, Carlos Óscar S. Sorzano, Luis Jordá, Laia Codó, Josep L. Gelpí, Marta Sisteré-Oró, Andreas Meyerhans, Kris Thielemans, Francisco Martínez-Jiménez, Núria López-Bigas, Felipe García, María J. Alonso, Montserrat Plana, Mariano Esteban, Carmen Elena Gómez
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/65c430fb91f54fc0aada194799ba02ca
Autor:
Mie Kobayashi-Ishihara, Katarína Frazão Smutná, Florencia E. Alonso, Jordi Argilaguet, Anna Esteve-Codina, Kerstin Geiger, Meritxell Genescà, Judith Grau-Expósito, Clara Duran-Castells, Selina Rogenmoser, René Böttcher, Jennifer Jungfleisch, Baldomero Oliva, Javier P. Martinez, Manqing Li, Michael David, Makoto Yamagishi, Marta Ruiz-Riol, Christian Brander, Yasuko Tsunetsugu-Yokota, Maria J. Buzon, Juana Díez, Andreas Meyerhans
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-15 (2023)
Abstract Latency is a major barrier towards virus elimination in HIV-1-infected individuals. Yet, the mechanisms that contribute to the maintenance of HIV-1 latency are incompletely understood. Here we describe the Schlafen 12 protein (SLFN12) as an
Externí odkaz:
https://doaj.org/article/fe8fd07aac2943398c12eb137cde748c
Autor:
Antoni Prenafeta, Gregori Bech-Sàbat, Alexandra Moros, Antonio Barreiro, Alex Fernández, Manuel Cañete, Mercè Roca, Luis González-González, Carme Garriga, Joachim Confais, Marion Toussenot, Hugues Contamin, Andrés Pizzorno, Manuel Rosa-Calatrava, Edwards Pradenas, Silvia Marfil, Julià Blanco, Paula Cebollada Rica, Marta Sisteré-Oró, Andreas Meyerhans, Cristina Lorca, Joaquim Segalés, Teresa Prat, Ricard March, Laura Ferrer
Publikováno v:
iScience, Vol 26, Iss 7, Pp 107224- (2023)
Summary: SARS-CoV-2 emerged in December 2019 and quickly spread worldwide, continuously striking with an unpredictable evolution. Despite the success in vaccine production and mass vaccination programs, the situation is not still completely controlle
Externí odkaz:
https://doaj.org/article/9369697d1b964e229177289631f80d99
Autor:
Ignasi Esteban, Carmen Pastor-Quiñones, Lorena Usero, Elena Aurrecoechea, Lorenzo Franceschini, Arthur Esprit, Josep Lluís Gelpí, Francisco Martínez-Jiménez, Núria López-Bigas, Karine Breckpot, Kris Thielemans, Lorna Leal, Carmen Elena Gómez, Marta Sisteré-Oró, Andreas Meyerhans, Mariano Esteban, María José Alonso, Felipe García, Montserrat Plana
Publikováno v:
Vaccines, Vol 12, Iss 1, p 15 (2023)
The COVID-19 pandemic has brought significant changes and advances in the field of vaccination, including the implementation and widespread use of encapsidated mRNA vaccines in general healthcare practice. Here, we present two new mRNAs expressing an
Externí odkaz:
https://doaj.org/article/5049aac8017e41528739adfc92cee953
Autor:
Antonio Barreiro, Antoni Prenafeta, Gregori Bech-Sabat, Mercè Roca, Eva Perozo Mur, Ricard March, Luis González-González, Laia Madrenas, Júlia Corominas, Alex Fernández, Alexandra Moros, Manuel Cañete, Mercè Molas, Thais Pentinat-Pelegrin, Clara Panosa, Alberto Moreno, Ester Puigvert Molas, Eva Pol Vilarrassa, Jordi Palmada, Carme Garriga, Teresa Prat Cabañas, Javier Iglesias-Fernández, Júlia Vergara-Alert, Cristina Lorca-Oró, Núria Roca, Leira Fernández-Bastit, Jordi Rodon, Mònica Pérez, Joaquim Segalés, Edwards Pradenas, Silvia Marfil, Benjamin Trinité, Raquel Ortiz, Bonaventura Clotet, Julià Blanco, Jorge Díaz Pedroza, Rosa Ampudia Carrasco, Yaiza Rosales Salgado, Jordina Loubat-Casanovas, Sara Capdevila Larripa, Julia Garcia Prado, Jordi Barretina, Marta Sisteré-Oró, Paula Cebollada Rica, Andreas Meyerhans, Laura Ferrer
Publikováno v:
iScience, Vol 26, Iss 3, Pp 106126- (2023)
Summary: Current COVID-19 vaccines have been associated with a decline in infection rates, prevention of severe disease, and a decrease in mortality rates. However, SARS-CoV-2 variants are continuously evolving, and development of new accessible COVI
Externí odkaz:
https://doaj.org/article/d0726f4810564a71891b55321b0794c7